Plan. Day 2: Exercise on MHC molecules.
|
|
- Preston Neal
- 5 years ago
- Views:
Transcription
1
2 Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel: Use of SVM in WEKA program Day 2: Exercise on MHC molecules.
3 Material Lectures and compendium are available on the course program site at CBS. Data set for the herg exercise and MHC exercises will have to be downloaded on your directory or your machine. WEKA program can be installed in your own machine or can be run from life server at CBS.
4
5
6
7 Drug discovery
8 Drug and drug design A drug is a key molecule involved in a particular metabolic or signaling pathway that is specific to a disease condition or pathology. Action of activation (agonist) or inhibition (antagonist) to a biological target (protein, receptor, enzymes, cells ). Drug design is the approach of finding drugs by design, based on their biological targets. An important part of drug design is the prediction of small molecules binding to a target protein (pharmacophore, docking, QSAR, )
9 Chemoinformatics- definition F.K. Brown (1998): Annual Reports in Medicinal Chemistry, 33, The use of information technology and management has become a critical part of the drug discovery process. Chemoinformatics is the mixing of those information resources to transform data into information and information into knowledge for the intended purpose of making better decisions faster in the area of drug lead identification and optimization.
10 Virtual screening- Chemoinformatics Exploit any knowledge of target(s) and/or active ligand(s) and/or gene family. It involves computational technique for a rapid assessment of large libraries of chemical structures in order to guide the selection of likely drug candidates. Structure based Docking Ligand based QSAR, similarity search VS Pharmacophore based knowledge based Chemical-Biology network
11 Drug-likeness with a simple counting method, rule of five Octanol-water partition coefficient (logp) 5 Molecular weight 500 No. hydrogen bond acceptors (HBA) 10 No. hydrogen bond donors (HBD) 5 If two or more of these rules are violated, the compound might have problems with oral bioavailability. (Lipinski et al., Adv. Drug Delivery Rev., 23, 1997, 3.) Rules have always exception. (antibiotics, antibacterials and antimicrobials, )
12 What the chemist sees. Aspirin Sildenafil
13 1D structure, line notation SMILES CC(=O)OC1=CC=CC=C1C(=O)O CCCC1=NN(C2=C1NC(=NC2=O)C3=C (C=CC(=C3)S(=O)(=O)N4CCN(CC4)C) OCC)C SMILES Simplified Molecular Line Entry System
14 Aspirin What a protein sees. Sildenafil Electrostatic fields (red are negative and blue positive)
15 Aspirin What a protein sees. Sildenafil Green are hydrophilic area and red are hydrophobic areas
16 Ligand based- QSAR Based on a set of experimental data (biological activity, solubility, toxicity, permeability, ) one tries to correlate these data with some descriptors. But what can be these descriptors?
17 Descriptors 1D descriptors: MW, number of features, sequence based MACCS key 2D descriptors: Topological, physichochemical, BCUT,
18 Descriptors QSAR based on 3 D interaction energies (GRID, CoMFA...) GRID: Determines a total interaction energy. Etot = Evdw + Eelec + Ehb Structural model Molecular interaction field (GRID) PCA and PLS model DRY O N1 H2O
19 Blue areas represent the favorable electronegative region and red the unfavorable electronegative regions (based on CoMFA) Green areas represent the favorable steric region and yellow the unfavorable steric regions (based on CoMFA).
20 The most common method used to correlate data are usually, PLS, SVM, ANN, K-means.
21 Example with Antimicrobial Peptides (AMPs) AMPs are small (10-40 amino acids), cationic and amphipatic molecules, which are encoded directly from DNA. They are ubiquitous in nature, appearing in such diverse organisms as fungi, bacteria, plants, amphibians, insects, and mammals, where they establish a first-line defence mechanism against invading pathogens or competing organisms. CAP1 8 Leucocin A Tritrpticin Defensin
22 Novispirin variant1 63 variant2 82 Activity S001 S002 S003 S131 Activity = y + as001 + bs zs131
23 Classification from a sequence based analysis Amino Acid z-scales Translate sequence information to a quantitative description 29 physicochemical descriptors reduced to 3 latent variables by Principal Component Analysis (PCA) Hellberg et al., J.Med.Chem. 30 (1987) 1126 Extended to non-natural amino acids Sandberg et al., J. Med. Chem. 41 (1998) 2481 Classification of GPCRs Lapinsh et al., Prot. Sci. 11 (2002) 795
24 Amino Acid z-scales Translate sequence information to a quantitative description 29 physicochemical descriptors reduced to 3 latent variables by Principal Component Analysis (PCA) z1 (lipophilicity) z2 (steric properties) z3 (electrostatic properties) Ala Phe Lys Principal Property Translation Hellberg et al., J.Med.Chem. 30 (1987) 1126
25 Novispirin: From sequences to data Principal property translation (z-scales) & multivariate data analysis 52 x 20 (52+n) x 60 z-scales PCA scores and QSAR models
26 training set of 52 Novispirin variants with 60 variables. q 2 loo =0.40 ; r2 =0.72 sdep =0.14
27 Novispirin: From structures to data 131 descriptors: - CPSA descriptors (charged partial surface area) computed with the Tripos force field, dipole moment, energies,surface, weight (33). - VolSurf descriptors defined interaction of molecules with biological membranes which is mediated by surface properties such as shape, electrostatic, hydrogen-bonding and hydrophobicity (94). - theoretical descriptors according of the hydrophobicity of each amino acid defined by Engleman-Steitz (4).
28 48 variables selected with a fractional factorial design (FFD). q 2 loo =0.64 ; r2 =0.79 sdep =0.11
29 Single mutation Novispirin prediction with a QSAR model. Each position of the Novispirin sequence is mutated with the 20 naturally amino acids. The residual activity of peptide variants is defined according of the wild type activity. Then, all point superior to 0 represent a peptide mutant with a better predict activity compared to the original novispirin.
30 Taboureau Methods Mol. Biol Taboureau et al. Chem.Biol.Drug.Des Raventos et al. CCHTS Mygind et al. Nature position 4
31 Pharmacophore Definition A pharmacophore is the ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target structure and to trigger (or to block) its biological response. A pharmacophore does not represent a real molecule or a real association of functional groups, but a purely abstract concept that accounts for the common molecular interaction capacities of a group of compounds towards their target structure.
32 Pharmacophore Pharmacophore: chemical features The chemical features can be hydrogen bonds acceptors, hydrogen bond donors, charge interactions, hydrophobic areas, aromatic rings, positive or negative ionizable group.) The shape or volume is also considered. Hyd Acc Acc Aro Acc & Don Start to be complex!!! Pharmacophores represent chemical functions, valid not only for the curretly bound, but also unknown molecules. The steric hindrance may explain lack of activity.
33 Pharmacophore Example 1 Atom is acceptor if it s a nitrogen, oxygen or sulfur and not an amide nitrogen, aniline nitrogen and sulfonyl sulfur and nitro group nitrogen Acceptor Donor Acceptor Aro ring center
34 Pharmacophore Example 2 with 3 inhibitors Agonist at D2 receptor Dopamine (2 rotations and 2 OH groups) Apomorphine (no rotations) 5-OH DPAT (one OH group and many rotation)
35 Pharmacophore Example 2 Active agonists define important groups: -Aromatic ring -meta OH group -N atom, righ distance from aromatic ring -other molecular scaffolding does NOT get in the way at the receptor
36 Pharmacophore
37 Pharmacophore
38 Are features of the site unique to herg?
39
40 Structural based design: Docking
41 Docking
42 Structural based design: Docking Comparison of some of the docking tools. Kellenberger E. et al. Proteins 2004, 57(2):
43 Structural based design: Docking Induced fit docking Substrate (ligand) + Enzyme Substrate (receptor) + (ligand) Enzyme (receptor) Lock and Key Induced Fit
44 Structural based design: an example with antidepressant Zhou, Sciences 2007
45 Chemogenomics and Pharmacogenomics Chemogenomics: Studied the biological effect of a wide array of small molecules on a wide array of macromolecular targets. Pharmacogenomics: Design drugs according of the genetic variation.
46 Chemical network: example with neurotransmitter transporters
47 Chemogenomics and Pharmacogenomics: an example with citalopram A441G CIT: 2.5x gain of function CIT with ears : 2x gain of function A441G V343S V343N V343S CIT: 4.5x gain of function Des-CN: 4.9x gain of function [Des-F: 7.4x gain of function] V343N CIT: 3.5x gain of function Des-CN: 35.5x gain of function [Des-F: 3.8x gain of function] A173S A173S CIT: 4.5x gain of function Des-F: 16.5x gain of function S438T S438T CIT: 175x loss of function Monomethyl: 3.5x loss of function
48 Chemogenomics and Pharmacogenomics: an example with citalopram A441G CIT: 2.5x gain of function CIT with ears : 2x gain of function A441G V343S V343N V343S CIT: 4.5x gain of function Des-CN: 4.9x gain of function [Des-F: 7.4x gain of function] V343N CIT: 3.5x gain of function Des-CN: 35.5x gain of function [Des-F: 3.8x gain of function] A173S A173S CIT: 4.5x gain of function Des-F: 16.5x gain of function S438T S438T CIT: 175x loss of function Monomethyl: 3.5x loss of function
49 Conclusion According of the information you have, different strategies can be used. If you can develop different strategies which come to the same conclusion, that will reinforce your hypothesis. The most information (experimental) you have, the better your validation will be.
50 Time for a break!!!
Structural biology and drug design: An overview
Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved
More informationPlan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.
Plan Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Exercise: Example and exercise with herg potassium channel: Use of
More informationIntroduction to Chemoinformatics and Drug Discovery
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013 The Chemical Space There are atoms and space. Everything else is opinion. Democritus (ca.
More informationReceptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
More informationStructure-Activity Modeling - QSAR. Uwe Koch
Structure-Activity Modeling - QSAR Uwe Koch QSAR Assumption: QSAR attempts to quantify the relationship between activity and molecular strcucture by correlating descriptors with properties Biological activity
More informationIn silico pharmacology for drug discovery
In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of
More informationPrinciples of Drug Design
Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction
More informationNonlinear QSAR and 3D QSAR
onlinear QSAR and 3D QSAR Hugo Kubinyi Germany E-Mail kubinyi@t-online.de HomePage www.kubinyi.de onlinear Lipophilicity-Activity Relationships drug receptor Possible Reasons for onlinear Lipophilicity-Activity
More informationIntroduction. OntoChem
Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads
More informationComputational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
More informationChemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller
Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics
More informationBioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA 30144 Dept. Chem. & Biochem. Kennesaw
More informationAdvanced Medicinal Chemistry SLIDES B
Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability
More information1. (18) Multiple choice questions. Please place your answer on the line preceding each question.
CEM 5720 ame KEY Exam 2 ctober 21, 2015 Read all questions carefully and attempt those questions you are sure of first. Remember to proof your work; art work carries as much importance as written responses.
More informationPatrick: An Introduction to Medicinal Chemistry 5e Chapter 01
Questions Patrick: An Introduction to Medicinal Chemistry 5e 01) Which of the following molecules is a phospholipid? a. i b. ii c. iii d. iv 02) Which of the following statements is false regarding the
More informationDrug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters
Drug Design 2 Oliver Kohlbacher Winter 2009/2010 11. QSAR Part 4: Selected Chapters Abt. Simulation biologischer Systeme WSI/ZBIT, Eberhard-Karls-Universität Tübingen Overview GRIND GRid-INDependent Descriptors
More informationHydrogen Bonding & Molecular Design Peter
Hydrogen Bonding & Molecular Design Peter Kenny(pwk.pub.2008@gmail.com) Hydrogen Bonding in Drug Discovery & Development Interactions between drug and water molecules (Solubility, distribution, permeability,
More informationComputational Methods and Drug-Likeness. Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004
Computational Methods and Drug-Likeness Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004 The Problem Drug development in pharmaceutical industry: >8-12 years time ~$800m costs >90% failure
More informationDrug Discovery. Zainab Al Kharusi Office: 33-10
Drug Discovery Zainab Al Kharusi Office: 33-10 Objectives: To understand the processes of Drug Development To be able to develop a plan for drug discovery Reference: Patrick G L. An Introduction to Medicinal
More informationDr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre
Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput
More informationNavigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland
Navigation in Chemical Space Towards Biological Activity Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland Data Explosion in Chemistry CAS 65 million molecules CCDC 600 000 structures
More informationSimilarity Search. Uwe Koch
Similarity Search Uwe Koch Similarity Search The similar property principle: strurally similar molecules tend to have similar properties. However, structure property discontinuities occur frequently. Relevance
More informationNext Generation Computational Chemistry Tools to Predict Toxicity of CWAs
Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs William (Bill) Welsh welshwj@umdnj.edu Prospective Funding by DTRA/JSTO-CBD CBIS Conference 1 A State-wide, Regional and National
More informationLec.1 Chemistry Of Water
Lec.1 Chemistry Of Water Biochemistry & Medicine Biochemistry can be defined as the science concerned with the chemical basis of life. Biochemistry can be described as the science concerned with the chemical
More informationMOLECULAR DRUG TARGETS
MOLECULAR DRUG TARGETS LEARNING OUTCOMES At the end of this session student shall be able to: List different types of druggable targets Describe forces involved in drug-receptor interactions Describe theories
More informationSaba Al Fayoumi. Tamer Barakat. Dr. Mamoun Ahram + Dr. Diala Abu-Hassan
1 Saba Al Fayoumi Tamer Barakat Dr. Mamoun Ahram + Dr. Diala Abu-Hassan What is BIOCHEMISTRY??? Biochemistry = understanding life Chemical reactions are what makes an organism (An organism is simply atoms
More informationImproved Descriptors for the Quantitative Structure Activity Relationship Modeling of Peptides and Proteins
Cite This: pubs.acs.org/jcim Improved Descriptors for the Quantitative Structure Activity Relationship Modeling of Peptides and Proteins Mark H. Barley, Nicholas J. Turner, and Royston Goodacre* School
More informationCHEM 4170 Problem Set #1
CHEM 4170 Problem Set #1 0. Work problems 1-7 at the end of Chapter ne and problems 1, 3, 4, 5, 8, 10, 12, 17, 18, 19, 22, 24, and 25 at the end of Chapter Two and problem 1 at the end of Chapter Three
More informationSupporting Information (Part II) for ACS Combinatorial Science
Supporting Information (Part II) for ACS Combinatorial Science Application of 6,7Indole Aryne Cycloaddition and Pd(0)Catalyzed SuzukiMiyaura and BuchwaldHartwig CrossCoupling Reactions for the Preparation
More informationOverview. Descriptors. Definition. Descriptors. Overview 2D-QSAR. Number Vector Function. Physicochemical property (log P) Atom
verview D-QSAR Definition Examples Features counts Topological indices D fingerprints and fragment counts R-group descriptors ow good are D descriptors in practice? Summary Peter Gedeck ovartis Institutes
More informationTargeting protein-protein interactions: A hot topic in drug discovery
Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,
More informationMolecular docking, 3D-QSAR studies of indole hydrazone as Staphylococcus aureus pyruvate kinase inhibitor
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationChemical library design
Chemical library design Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery Today,
More informationASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS
Page109 IJPBS Volume 5 Issue 1 JAN-MAR 2015 109-114 Research Article Pharmaceutical Sciences ASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS Department of Pharmaceutical Chemistry, Institute
More informationEarly Stages of Drug Discovery in the Pharmaceutical Industry
Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery
More informationIntroduction into Biochemistry. Dr. Mamoun Ahram Lecture 1
Introduction into Biochemistry Dr. Mamoun Ahram Lecture 1 Course information Recommended textbooks Biochemistry; Mary K. Campbell and Shawn O. Farrell, Brooks Cole; 7 th edition Instructors Dr. Mamoun
More informationVirtual screening in drug discovery
Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery
More informationCOMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS
COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS DRUG DEVELOPMENT Drug development is a challenging path Today, the causes of many diseases (rheumatoid arthritis, cancer, mental diseases, etc.)
More informationFRAUNHOFER IME SCREENINGPORT
FRAUNHOFER IME SCREENINGPORT Design of screening projects General remarks Introduction Screening is done to identify new chemical substances against molecular mechanisms of a disease It is a question of
More informationMedicinal Chemistry/ CHEM 458/658 Chapter 3- SAR and QSAR
Medicinal Chemistry/ CHEM 458/658 Chapter 3- SAR and QSAR Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Introduction Structure-Activity Relationship (SAR) - similar
More informationQuantitative Structure-Activity Relationship (QSAR) computational-drug-design.html
Quantitative Structure-Activity Relationship (QSAR) http://www.biophys.mpg.de/en/theoretical-biophysics/ computational-drug-design.html 07.11.2017 Ahmad Reza Mehdipour 07.11.2017 Course Outline 1. 1.Ligand-
More informationMachine learning for ligand-based virtual screening and chemogenomics!
Machine learning for ligand-based virtual screening and chemogenomics! Jean-Philippe Vert Institut Curie - INSERM U900 - Mines ParisTech In silico discovery of molecular probes and drug-like compounds:
More informationMolecular Interactions F14NMI. Lecture 4: worked answers to practice questions
Molecular Interactions F14NMI Lecture 4: worked answers to practice questions http://comp.chem.nottingham.ac.uk/teaching/f14nmi jonathan.hirst@nottingham.ac.uk (1) (a) Describe the Monte Carlo algorithm
More informationUsing Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface
Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites Introduction J. Andrew Surface Hampden-Sydney College / Virginia Commonwealth University In the past several decades
More informationPrinciples of Drug Design
(16:663:502) Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu For more current information, please check WebCT at https://webct.rutgers.edu
More informationDocking. GBCB 5874: Problem Solving in GBCB
Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular
More informationRelative Drug Likelihood: Going beyond Drug-Likeness
Relative Drug Likelihood: Going beyond Drug-Likeness ACS Fall National Meeting, August 23rd 2012 Matthew Segall, Iskander Yusof Optibrium, StarDrop, Auto-Modeller and Glowing Molecule are trademarks of
More informationQSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression
APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor
More informationMachine Learning Concepts in Chemoinformatics
Machine Learning Concepts in Chemoinformatics Martin Vogt B-IT Life Science Informatics Rheinische Friedrich-Wilhelms-Universität Bonn BigChem Winter School 2017 25. October Data Mining in Chemoinformatics
More informationUsing AutoDock for Virtual Screening
Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying
More informationExploring the black box: structural and functional interpretation of QSAR models.
EMBL-EBI Industry workshop: In Silico ADMET prediction 4-5 December 2014, Hinxton, UK Exploring the black box: structural and functional interpretation of QSAR models. (Automatic exploration of datasets
More information* Author to whom correspondence should be addressed; Tel.: ; Fax:
Int. J. Mol. Sci. 2011, 12, 946-970; doi:10.3390/ijms12020946 OPEN ACCESS Article International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Structural Determination of Three
More informationChapter 8: Introduction to QSAR
: Introduction to 8) Chapter 8: 181 8.1 Introduction to 181 8.2 Objectives of 181 8.3 Historical development of 182 8.4 Molecular descriptors used in 183 8.5 Methods of 185 8.5.1 2D methods 186 8.6 Introduction
More informationData Quality Issues That Can Impact Drug Discovery
Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,
More informationDrug Informatics for Chemical Genomics...
Drug Informatics for Chemical Genomics... An Overview First Annual ChemGen IGERT Retreat Sept 2005 Drug Informatics for Chemical Genomics... p. Topics ChemGen Informatics The ChemMine Project Library Comparison
More informationschematic diagram; EGF binding, dimerization, phosphorylation, Grb2 binding, etc.
Lecture 1: Noncovalent Biomolecular Interactions Bioengineering and Modeling of biological processes -e.g. tissue engineering, cancer, autoimmune disease Example: RTK signaling, e.g. EGFR Growth responses
More informationRetrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
More informationKeywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction
PostDoc Journal Vol. 2, No. 3, March 2014 Journal of Postdoctoral Research www.postdocjournal.com QSAR Study of Thiophene-Anthranilamides Based Factor Xa Direct Inhibitors Preetpal S. Sidhu Department
More informationbcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012
bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP
More informationA Review on Computational Methods in Developing Quantitative Structure-Activity Relationship (QSAR)
Navdeep Singh Sethi: A Review on Computational Methods in Developing Quantitative Structure-Activity 815 International Journal of Drug Design and Discovery Volume 3 Issue 3 July September 2012. 815-836
More informationJCICS Major Research Areas
JCICS Major Research Areas Chemical Information Text Searching Structure and Substructure Searching Databases Patents George W.A. Milne C571 Lecture Fall 2002 1 JCICS Major Research Areas Chemical Computation
More information3D-QSAR Studies on Angiotensin-Converting Enzyme (ACE) Inhibitors: a Molecular Design in Hypertensive Agents
952 Bull. Korean Chem. Soc. 2005, Vol. 26, No. 6 Amor A. San Juan and Seung Joo Cho 3D-QSAR Studies on Angiotensin-Converting Enzyme (ACE) Inhibitors: a Molecular Design in Hypertensive Agents Amor A.
More informationFragment Hotspot Maps: A CSD-derived Method for Hotspot identification
Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Chris Radoux www.ccdc.cam.ac.uk radoux@ccdc.cam.ac.uk 1 Introduction Hotspots Strongly attractive to organic molecules Organic molecules
More informationChimica Farmaceutica
Chimica Farmaceutica Drug Targets Why should chemicals, some of which have remarkably simple structures, have such an important effect «in such a complicated and large structure as a human being? The answer
More informationPing-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.
Pharmacophore-based Drug design Ping-Chiang Lyu Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University 96/08/07 Outline Part I: Analysis The analytical
More informationLigand-receptor interactions
University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine
More informationVirtual screening for drug discovery. Markus Lill Purdue University
Virtual screening for drug discovery Markus Lill Purdue University mlill@purdue.edu Lecture material http://people.pharmacy.purdue.edu/~mlill/teaching/eidelberg/ I.1 Drug discovery Cl N Disease I.1 Drug
More informationQuantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability
Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability Optibrium Webinar 2015, June 17 2015 Jonathan Tyzack, Matthew Segall, Peter Hunt Optibrium, StarDrop, Auto-Modeller
More information5.1. Hardwares, Softwares and Web server used in Molecular modeling
5. EXPERIMENTAL The tools, techniques and procedures/methods used for carrying out research work reported in this thesis have been described as follows: 5.1. Hardwares, Softwares and Web server used in
More informationSolved and Unsolved Problems in Chemoinformatics
Solved and Unsolved Problems in Chemoinformatics Johann Gasteiger Computer-Chemie-Centrum University of Erlangen-Nürnberg D-91052 Erlangen, Germany Johann.Gasteiger@fau.de Overview objectives of lecture
More informationLigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer
LigandScout Automated Structure-Based Pharmacophore Model Generation Gerhard Wolber* and Thierry Langer * E-Mail: wolber@inteligand.com Pharmacophores from LigandScout Pharmacophores & the Protein Data
More informationJournal of Pharmacology and Experimental Therapy-JPET#172536
A NEW NON-PEPTIDIC INHIBITOR OF THE 14-3-3 DOCKING SITE INDUCES APOPTOTIC CELL DEATH IN CHRONIC MYELOID LEUKEMIA SENSITIVE OR RESISTANT TO IMATINIB Manuela Mancini, Valentina Corradi, Sara Petta, Enza
More informationIntroduction to medicinal chemisry
2017 1 st edition Introduction to medicinal chemisry Med Chem I Mohammed Nooraldeen (PhD) كيمياء دوائية )1 ) محمد نورالدين محمود Introduction to medicinal chemistry Medicinal Chemistry Biology Medicine
More informationAqueous solutions. Solubility of different compounds in water
Aqueous solutions Solubility of different compounds in water The dissolution of molecules into water (in any solvent actually) causes a volume change of the solution; the size of this volume change is
More informationIntroductory Biochemistry
Introductory Biochemistry Instructors Dr. Nafez Abu Tarboush Dr. Mamoun Ahram Recommended textbooks Biochemistry; Mary K. Campbell and Shawn O. Farrell, Brooks Cole; 6 th edition Recommended electronic
More informationChemoinformatics and Drug Discovery
Molecules 2002, 7, 566-600 molecules ISSN 1420-3049 http://www.mdpi.org Review: Chemoinformatics and Drug Discovery Jun Xu* and Arnold Hagler Discovery Partners International, Inc., 9640 Towne Center Drive,
More informationBiochemistry,530:,, Introduc5on,to,Structural,Biology, Autumn,Quarter,2015,
Biochemistry,530:,, Introduc5on,to,Structural,Biology, Autumn,Quarter,2015, Course,Informa5on, BIOC%530% GraduateAlevel,discussion,of,the,structure,,func5on,,and,chemistry,of,proteins,and, nucleic,acids,,control,of,enzyma5c,reac5ons.,please,see,the,course,syllabus,and,
More informationCHM333 LECTURES 4 & 5: 8/31 9/2/07 FALL 2009 Professor Christine Hrycyna HOW ARE AMINO ACIDS MADE?
HOW ARE AMINO ACIDS MADE? - Many organisms can make all 20 of the amino acids o Bacteria, yeast, and plants - Some amino acids are made from common metabolic intermediates directly o For example, alanine
More informationAcids and Bases. Moore, T. (2016). Acids and Bases. Lecture presented at PHAR 422 Lecture in UIC College of Pharmacy, Chicago.
Acids and Bases Moore, T. (2016). Acids and Bases. Lecture presented at PHAR 422 Lecture in UIC College of Pharmacy, Chicago. Drug dissolution can impact buffering capacity of the body Most enzymes require
More informationSolutions and Non-Covalent Binding Forces
Chapter 3 Solutions and Non-Covalent Binding Forces 3.1 Solvent and solution properties Molecules stick together using the following forces: dipole-dipole, dipole-induced dipole, hydrogen bond, van der
More informationAlkane/water partition coefficients and hydrogen bonding. Peter Kenny
Alkane/water partition coefficients and hydrogen bonding Peter Kenny (pwk.pub.2008@gmail.com) Neglect of hydrogen bond strength: A recurring theme in medicinal chemistry Rule of 5 Rule of 3 Scoring functions
More informationMolecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..
3 Conformational Search Molecular Docking Simulate Annealing Ab Initio QM Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,.. Rino Ragno:
More informationStudies of New Fused Benzazepine as Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics
Int. J. Mol. Sci. 2011, 12, 1196-1221; doi:10.3390/ijms12021196 OPEN ACCESS Article International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Studies of New Fused Benzazepine
More informationMEDICINAL CHEMISTRY Homework 2 - ANSWERS
MEDICIAL CEMISTY omework 2 - ASWES 1. eceptor binding curves. Make a plot of %drug-bound versus -log[drug] for a drug whose K D is 5 x 10-6 M. Make a plot of %drug-bound vs [drug] for this same system.
More informationCreating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner
Table of Contents Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Features
More informationBiological Macromolecules
Introduction for Chem 493 Chemistry of Biological Macromolecules Dr. L. Luyt January 2008 Dr. L. Luyt Chem 493-2008 1 Biological macromolecules are the molecules of life allow for organization serve a
More informationSolvent & geometric effects on non-covalent interactions
Solvent & geometric effects on non-covalent interactions Scott L. Cockroft PhysChem Forum 10, Syngenta, Jealott s Hill, 23 rd March 11 QSAR & Physical Organic Chemistry Quantifiable Physicochemical Properties
More information9/25/2011. Outline. Overview: The Energy of Life. I. Forms of Energy II. Laws of Thermodynamics III. Energy and metabolism IV. ATP V.
Chapter 8 Introduction to Metabolism Outline I. Forms of Energy II. Laws of Thermodynamics III. Energy and metabolism IV. ATP V. Enzymes Overview: The Energy of Life Figure 8.1 The living cell is a miniature
More informationIgnasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015
Ignasi Belda, PhD CEO HPC Advisory Council Spain Conference 2015 Business lines Molecular Modeling Services We carry out computational chemistry projects using our selfdeveloped and third party technologies
More informationIdentifying Interaction Hot Spots with SuperStar
Identifying Interaction Hot Spots with SuperStar Version 1.0 November 2017 Table of Contents Identifying Interaction Hot Spots with SuperStar... 2 Case Study... 3 Introduction... 3 Generate SuperStar Maps
More informationOpen PHACTS Explorer: Compound by Name
Open PHACTS Explorer: Compound by Name This document is a tutorial for obtaining compound information in Open PHACTS Explorer (explorer.openphacts.org). Features: One-click access to integrated compound
More informationChemoinformatics and information management. Peter Willett, University of Sheffield, UK
Chemoinformatics and information management Peter Willett, University of Sheffield, UK verview What is chemoinformatics and why is it necessary Managing structural information Typical facilities in chemoinformatics
More informationResearch of New Class C beta-lactamase Inhibitor by Molecular Docking s Method
Journal of Computational Methods in Molecular Design, 2018, 8 (1):26-32 ISSN : 2231-3176 CODEN (USA): JCMMD Research of New Class C beta-lactamase Inhibitor by Molecular Docking s Method Benhamoud Amina,
More informationBIOLOGY 10/11/2014. An Introduction to Metabolism. Outline. Overview: The Energy of Life
8 An Introduction to Metabolism CAMPBELL BIOLOGY TENTH EDITION Reece Urry Cain Wasserman Minorsky Jackson Outline I. Forms of Energy II. Laws of Thermodynamics III. Energy and metabolism IV. ATP V. Enzymes
More informationCHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS
159 CHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS 6.1 INTRODUCTION The purpose of this study is to gain on insight into structural features related the anticancer, antioxidant
More informationUsing Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017
Using Phase for Pharmacophore Modelling 5th European Life Science Bootcamp March, 2017 Phase: Our Pharmacohore generation tool Significant improvements to Phase methods in 2016 New highly interactive interface
More informationBuild_model v User Guide
Build_model v.2.0.1 User Guide MolTech Build_model User Guide 2008-2011 Molecular Technologies Ltd. www.moltech.ru Please send your comments and suggestions to contact@moltech.ru. Table of Contents Input
More informationMedicinal Chemistry/ CHEM 458/658 Chapter 8- Receptors and Messengers
Medicinal Chemistry/ CHEM 458/658 Chapter 8- Receptors and Messengers Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Introduction Receptor specific areas of proteins
More informationPerforming a Pharmacophore Search using CSD-CrossMiner
Table of Contents Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Searching with a Pharmacophore... 4 Performing a Pharmacophore Search using CSD-CrossMiner Version 2.0
More informationAntimicrobial peptides
Název: Školitel: Antimicrobial peptides Zbyněk Heger Datum: 2. 8. 2013 Reg.č.projektu: CZ.1.07/2.4.00/31.0023 Název projektu: Partnerská síť centra excelentního bionanotechnologického výzkumu 2 Content
More information